HERO Act
Summary
The HERO Act (HR 7994) would establish a grant program for schools to purchase opioid overdose reversal drugs, boosting demand for naloxone manufacturers like Emergent BioSolutions. The bill has been forwarded by subcommittee to full committee, indicating some momentum, but no specific funding amount is authorized.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The HERO Act aims to increase naloxone availability in schools through a grant program.
- 2.Emergent BioSolutions ($EBS) is the primary manufacturer of Narcan, the most widely used opioid overdose reversal drug.
- 3.The bill is still in committee; no funding amount is specified, so the impact is modest and contingent on future appropriations.
Market Implications
The bill's progress is a positive signal for the opioid reversal drug market, particularly for $EBS. However, without a specific authorized funding level, the near-term revenue impact is uncertain. The stock may see modest upward pressure on legislative momentum, but significant gains require passage and appropriation.
Full Analysis
The HERO Act, introduced by Rep. Ruiz, would create a competitive grant program through HHS to help schools purchase FDA-approved opioid overdose reversal drugs (primarily naloxone) and develop educational programming. The bill was forwarded by the Subcommittee on Health to the full Committee on Energy and Commerce on June 25, 2026, via voice vote. It is still in the early legislative stages and has not yet been voted on by the full House or Senate. The bill does not specify an authorized funding amount, meaning actual appropriations would be determined separately. The primary beneficiaries are naloxone manufacturers, with Emergent BioSolutions ($EBS) being the leading producer of Narcan. The bill also requires schools receiving federal funds to report any distribution of opioid reversal drugs, which marginally increases administrative burden on schools but does not have direct market impact. The legislative path forward includes consideration by the full Energy and Commerce Committee, then the House floor, and potentially Senate action. Given the bipartisan nature of opioid-related legislation, the bill has moderate chances of eventual passage, but the lack of a specific dollar amount limits near-term revenue visibility.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Grant program authorized for schools to purchase opioid overdose reversal drugs; reporting requirement for distributions.
Who must act
Schools and local educational agencies receiving federal funds.
What happens
Increased procurement of naloxone and other opioid reversal drugs by schools, boosting demand.
Stock impact
Emergent BioSolutions manufactures Narcan (naloxone nasal spray), the leading brand. The grant program could increase school purchases, contributing to revenue growth in its naloxone product line.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $874M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $903M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →